James McCloskey 11, MD

Hematologist and medical oncologist, Chief, Leukemia Division

location_city Hackensack - John Theurer Cancer Center

9 years treating Acute Myeloid Leukemia

Clinical Expertise

Dr. McCloskey's research focus is on phase I/II non-randomized study of birinapant in combination with decitabine in patients with relapsed or refractory myelodysplastic syndrome and acute myelogenous leukemia, and was a primary investigator of cellular and molecular characterization of the immune response and minimal residual disease in patients who have completed treatment for acute myeloid leukemia.